IN-HOME AKI Monitoring in Cancer Patients: From Concept to Clinical Evaluation

View on-demand - instant access following registration

The IN-HOME study assesses the feasibility and acceptability of using a whole-blood creatinine point-of-care testing device (NOVA Biomedical StatSensor® Xpress) in the home, to monitor patient kidney function whilst receiving anticancer treatments that are potentially toxic to the kidneys.

Improved monitoring of kidney function could potentially lead to earlier detection of adverse renal events and improve patient outcomes. This could also alleviate the risk of patients with reduced kidney function going on to clinical trials.

This webinar will cover the end-to-end process that the team has gone through from initial idea, device selection and working with patients and healthcare professional to design an appropriate study to evaluate the feasibility of using the technology in the patient’s home. Key learnings to date from the practical delivery of a research study into the UK NHS will also be shared.  

​​​​​​​Ideal for anyone trying to develop and evaluate a device / technology / digital solution for delivering benefit to patients.  
​​​​​​​​​​​​​​

Your details

By submitting this form you are agreeing to our Terms & Conditions and Privacy Policy, and agree to receiving relevant emails from The Evidence Base about the latest news and editorial features.

Terms & Conditions

I agree to receive third party emails to keep me informed of relevant products and services relevant to my industry.

Subscribing to

Confirm sign-up

What you will learn:

Practical insight into the design and set-up of a research study in the UK NHS
The importance of engaging with patients to optimize study design and deliver maximum benefit
Understanding of the complexities and challenges associated with clinical research

Moderated by:

Jenny Royle
Strategic Lead, MediPaCe (London, UK)

Trained in biochemistry, pharmacology and psychology/behavior change, Jenny spent many years in pharma designing trials, analyzing data, supporting products, and establishing patient-centric functions.

She has also been a founding leader, and Chief-Investigator in a novel academic research team that optimized healthcare decision science and involved collaboration between pharma, academia, NHS and charities.

Speaker:

Leanna Goodwin
Research Practitioner, The Christie Hospital and digital ECMT (Cancer Research UK Cancer Biomarker Centre)

Leanna Goodwin is a Research Practitioner in the digital Experimental Cancer Medicine Team based at The Christie NHS Foundation Trust in Manchester, UK. Leanna works in this patient-facing role on Technology Clinical Trials, which seek to collaborate with patients and healthcare professionals to use technology to develop innovative care pathways.

Share this webinar